Surgery Partners (SGRY) Net Equity Issued and Repurchased (2021 - 2022)

Surgery Partners (SGRY) posted Net Equity Issued and Repurchased of $882.9 million for Q4 2022, up 175.13% sequentially from $320.9 million in Q4 2021, and up 175.13% YoY from $320.9 million in Q4 2021.

Surgery Partners (SGRY) Net Equity Issued and Repurchased (2021 - 2022) Analysis & Trends

Surgery Partners has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $882.9 million in Q4 2022.

  • Quarterly Net Equity Issued and Repurchased rose 175.13% year-over-year to $882.9 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $882.9 million (up 51.75% YoY) and the FY2022 annual result came in at $882.9 million, up 51.75% from the prior year.
  • Net Equity Issued and Repurchased improved to $882.9 million in Q4 2022 per SGRY's latest filing, from $320.9 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $882.9 million in Q4 2022 and troughed at $260.9 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn -
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn -
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn -
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn -
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn -
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn 4.88 Mn
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn -
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn -
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn -
10 Surgery Partners 1.97 Bn 3.18 Bn 622.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 882.90 Mn
Dec 31, 2022 882.90 Mn
Dec 31, 2021 320.90 Mn
Dec 31, 2021 320.90 Mn
Mar 31, 2021 260.90 Mn
Mar 31, 2021 260.90 Mn